📣 VC round data is live. Check it out!

Ilex Medical Valuation Multiples

Discover Ilex Medical's revenue and EBITDA valuation multiples and investment history, alongside public comparables like RxSight, TriSalus Life Sciences, Asterasys, Medinice and more.

Ilex Medical Overview

About Ilex Medical

Ilex Medical Ltd is an Israel based company engages in the marketing and distribution of diagnostic products and other medical laboratory information systems. It offers in-vitro diagnostic equipment, reagents, laboratory management software, blood bank diagnostic kits, and diagnostic support services to the healthcare sector in Israel.


Founded

1977

HQ

Israel

Employees

N/A

Financials (FY)

Revenue: $330M
EBITDA: $45M

EV

$145M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ilex Medical Financials

Ilex Medical reported last fiscal year revenue of $330M and EBITDA of $45M.

In the same fiscal year, Ilex Medical generated $75M in gross profit, $45M in EBITDA, and $20M in net income.


Ilex Medical P&L

In the most recent fiscal year, Ilex Medical reported revenue of $330M and EBITDA of $45M.

Ilex Medical is profitable as of last fiscal year, with gross margin of 23%, EBITDA margin of 14%, and net margin of 6%.

See analyst estimates for Ilex Medical
Last FY202320242025202620272028
Revenue$330M$330M$326M$330M
Gross Profit$75M$82M$77M$75M
Gross Margin23%25%24%23%
EBITDA$45M$42M$40M$45M
EBITDA Margin14%13%12%14%
EBIT Margin6%8%7%6%
Net Profit$20M$18M$14M$20M
Net Margin6%5%4%6%

Financial data powered by Morningstar, Inc.

Ilex Medical Stock Performance

Ilex Medical has current market cap of $204M, and enterprise value of $145M.

Market Cap Evolution


Ilex Medical's stock price is $18.23.

Ilex Medical share price decreased by 0.9% in the last 30 days, and by 12.2% in the last year.

Ilex Medical has an EPS (earnings per share) of $1.76.

See more trading valuation data for Ilex Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$145M$204M-0.1%-0.9%-10.8%-12.2%$1.76

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ilex Medical Valuation Multiples

Ilex Medical trades at 0.4x EV/Revenue multiple, and 3.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Ilex Medical

Ilex Medical Financial Valuation Multiples

As of June 3, 2026, Ilex Medical has market cap of $204M and EV of $145M.

Ilex Medical has a P/E ratio of 10.4x.

Last FY202320242025202620272028
EV/Revenue0.4x0.4x0.4x0.4x
EV/EBITDA3.3x3.4x3.6x3.3x
EV/EBIT7.3x5.6x6.3x7.3x
EV/Gross Profit1.9x1.8x1.9x1.9x
P/E10.4x11.3x14.8x10.4x
EV/FCF9.6x14.5x8.5x9.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ilex Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ilex Medical Margins & Growth Rates

In the most recent fiscal year, Ilex Medical reported gross margin of 23%, EBITDA margin of 14%, and net margin of 6%.

See estimated margins and future growth rates for Ilex Medical

Ilex Medical Margins

Last FY20242025202720282029
Gross Margin23%24%23%
EBITDA Margin14%12%14%
EBIT Margin6%7%6%
Net Margin6%4%6%
FCF Margin5%5%5%

Ilex Medical Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(1%)1%
Gross Profit Growth(7%)(2%)
EBITDA Growth(5%)11%
EBIT Growth(12%)(14%)
Net Profit Growth(23%)43%
FCF Growth71%(11%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Ilex Medical Operational KPIs

Access forward-looking KPIs for Ilex Medical
Last FY202320242025202620272028
S&M Expenses to Revenue1%1%1%1%
G&A Expenses to Revenue1%1%1%1%
R&D Expenses to Revenue1%1%1%1%
Opex to Revenue17%17%16%17%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Ilex Medical Competitors

Ilex Medical competitors include RxSight, TriSalus Life Sciences, Asterasys, Medinice, Lucid Diagnostics, Sanara MedTech, Pro-Dex, Huons Co, Utah Medical and Anika Therapeutics.

Most Ilex Medical public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
RxSight(0.0x)(0.0x)0.1x0.0x
TriSalus Life Sciences4.0x3.7x(11.1x)(12.2x)
Asterasys7.5x6.3x22.7x18.2x
Medinice--(111.9x)-
Lucid Diagnostics44.1x35.6x(3.7x)(4.0x)
Sanara MedTech2.2x2.1x13.6x13.7x
Pro-Dex3.3x2.9x15.7x-
Huons Co0.7x-5.2x-

This data is available for Pro users. Sign up to see all Ilex Medical competitors and their valuation data.

Start Free Trial

Investments by Ilex Medical

Ilex Medical has invested in 2 companies to date.

Latest investment by Ilex Medical was on February 18th 2026. Ilex Medical invested in Starget Pharma in their $18M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Ilex Medical

Starget Pharma
Scopio Labs
Description
Starget Pharma is a clinical-stage radiopharmaceutical company developing targeted therapies for solid tumors. Its pipeline features alpha-emitter conjugates that selectively deliver radioisotopes to prostate, lung, and other cancer tissues. Headquartered in Montreal, Canada, the firm advances molecules through phase I and II trials.
Scopio Labs is a Tel Aviv-headquartered provider of full-field digital morphology systems for hematology. The platform uses AI to analyze high-resolution images from blood samples and bone marrow aspirates, revealing thousands of cells for advanced diagnostic insights. Scopio enables hematologists to uncover previously inaccessible data patterns in routine samples.
HQ CountryIsraelIsrael
HQ City
Ramat HaSharon
Tel Aviv
Deal Date18 Feb 20269 Feb 2022
RoundSeries ASeries C
Raised$18M$50M
InvestorsBRF; Cancer Focus Fund; Ilex Medical; Louisiana Economic DevelopmentAurum Ventures MKI; Ilex Medical; LR Group; Lumir Ventures; Mivtach Shamir Holdings; Mizrahi-Tefahot Bank; OTV; OurCrowd
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Ilex Medical investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ilex Medical

When was Ilex Medical founded?Ilex Medical was founded in 1977.
Where is Ilex Medical headquartered?Ilex Medical is headquartered in Israel.
Is Ilex Medical publicly listed?Yes, Ilex Medical is a public company listed on Tel Aviv Stock Exchange.
What is the stock symbol of Ilex Medical?Ilex Medical trades under ILX ticker.
When did Ilex Medical go public?Ilex Medical went public in 1995.
Who are competitors of Ilex Medical?Ilex Medical main competitors include RxSight, TriSalus Life Sciences, Asterasys, Medinice, Lucid Diagnostics, Sanara MedTech, Pro-Dex, Huons Co, Utah Medical, Anika Therapeutics.
What is the current market cap of Ilex Medical?Ilex Medical's current market cap is $204M.
What is the current revenue of Ilex Medical?Ilex Medical's last fiscal year revenue is $330M.
What is the current EV/Revenue multiple of Ilex Medical?Current revenue multiple of Ilex Medical is 0.4x.
Is Ilex Medical profitable?No, Ilex Medical is not profitable.
How many companies Ilex Medical has acquired to date?Ilex Medical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Ilex Medical has invested to date?As of June 2026, Ilex Medical has invested in 2 companies.
What was the last Ilex Medical investment?On 18th February 2026 Ilex Medical invested in Starget Pharma, participating in a $18M Series A round, alongside BRF, Cancer Focus Fund, and Louisiana Economic Development.
In what companies Ilex Medical invested in?Ilex Medical invested in Scopio Labs and Starget Pharma.

See public comps similar to Ilex Medical

Lists including Ilex Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial